Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$780M |
| 2 |
Uber
UBER
|
+$708M |
| 3 |
Goldman Sachs
GS
|
+$569M |
| 4 |
Microsoft
MSFT
|
+$430M |
| 5 |
Netflix
NFLX
|
+$415M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$973M |
| 2 |
Intuitive Surgical
ISRG
|
+$872M |
| 3 |
Nike
NKE
|
+$844M |
| 4 |
Edwards Lifesciences
EW
|
+$805M |
| 5 |
Corpay
CPAY
|
+$701M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.66% |
| 2 | Consumer Discretionary | 19.04% |
| 3 | Healthcare | 13.04% |
| 4 | Communication Services | 12.22% |
| 5 | Financials | 10.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
Brookfield Renewable
BEP
$9.96B
| $8.39M | 0.01% |
+370,543
| New | +$9.38M |
|
352
Kinross Gold
KGC
$32.8B
| $8.3M | 0.01% |
+2,086,577
| New | +$10.1M |
|
353
Pentair
PNR
$11B
| $8.19M | 0.01% |
275,249
+118,933
| +76% | +$4.78M |
|
|
FFWM
354
DELISTED
First Foundation Inc
FFWM
| $8.03M | 0.01% |
785,212
+205,106
| +35% | +$3.03M |
|
355
JELD-WEN Holding
JELD
$164M
| $7.95M | 0.01% |
816,886
-51,301
| -6% | -$1.02M |
|
356
EOG Resources
EOG
$70.7B
| $7.89M | 0.01% |
219,678
-23,585
| -10% | -$1.53M |
|
|
SAND
357
DELISTED
Sandstorm Gold
SAND
| $7.86M | 0.01% |
1,569,629
-12,522
| -0.8% | -$80K |
|
|
CXO
358
DELISTED
CONCHO RESOURCES INC.
CXO
| $7.76M | 0.01% |
181,187
+1,896
| +1% | +$132K |
|
359
Denali Therapeutics
DNLI
$3.94B
| $7.68M | 0.01% |
+438,879
| New | +$9.16M |
|
360
Stoneridge
SRI
$213M
| $7.5M | 0.01% |
447,927
+142,660
| +47% | +$3.54M |
|
361
Oneok
OKE
$54.5B
| $7.49M | 0.01% |
343,457
-1,622,505
| -83% | -$98.9M |
|
362
iRhythm Holdings
IRTC
$4.2B
| $7.49M | 0.01% |
92,054
-62,727
| -41% | -$5.2M |
|
363
CRISPR Therapeutics
CRSP
$5.17B
| $7.49M | 0.01% |
+176,499
| New | +$9.11M |
|
|
THR
364
DELISTED
Thermon Group Holdings
THR
| $7.46M | 0.01% |
494,722
+16,886
| +4% | +$351K |
|
365
Energy Transfer Partners
ET
$69.3B
| $7.41M | 0.01% |
1,610,348
-1,364,629
| -46% | -$14.5M |
|
366
Phreesia
PHR
$773M
| $7.39M | 0.01% |
351,429
-58,884
| -14% | -$1.61M |
|
367
ON Semiconductor
ON
$19.3B
| $7.35M | 0.01% |
+591,105
| New | +$11.6M |
|
368
Cytokinetics
CYTK
$10.4B
| $7.24M | 0.01% |
614,154
+4,190
| +0.7% | +$53.5K |
|
369
Gossamer Bio
GOSS
$87M
| $7.2M | 0.01% |
709,433
+104,134
| +17% | +$1.36M |
|
370
Acadia Pharmaceuticals
ACAD
$5.03B
| $7.07M | 0.01% |
167,227
+17,642
| +12% | +$727K |
|
371
FIVE9
FIVN
$2.6B
| $7.02M | 0.01% |
+91,859
| New | +$6.55M |
|
|
SWTX
372
DELISTED
SpringWorks Therapeutics
SWTX
| $6.85M | 0.01% |
253,654
+2,207
| +0.9% | +$72K |
|
373
Western Digital
WDC
$150B
| $6.54M | 0.01% |
207,777
+197,967
| +2,018% | +$8.77M |
|
374
BP
BP
$107B
| $6.51M | 0.01% |
266,756
-160,604
| -38% | -$5.19M |
|
|
SAGE
375
DELISTED
Sage Therapeutics
SAGE
| $6.25M | 0.01% |
217,667
-213,542
| -50% | -$12.4M |
|
Similar funds
Jennison Associates's Q1 2020 Portfolio in Review
As of Q1 2020, Jennison Associates held 749 positions worth $82.3B, down 17% from $99.1B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Jennison Associates withdrew a net $4.86B in Q1 2020, closing 131 positions and reducing 247 holdings. Its most notable exit was Parker-Hannifin, an estimated $116M position sold in full.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 27% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Jennison Associates opened a new position in Atlassian worth $350M.
- Jennison Associates's largest Q1 2020 buy was Atlassian: 2,552,272 shares worth $350M.
- Jennison Associates added most to Eli Lilly in Q1 2020, an estimated $780M increase.
- Jennison Associates's biggest Q1 2020 reduction was Walt Disney, cutting an estimated $973M.
- Jennison Associates fully exited Parker-Hannifin in Q1 2020, selling an estimated $116M.
- Jennison Associates's ten largest holdings make up 40% of its $82.3B portfolio in Q1 2020.
- Jennison Associates opened 131 new positions and closed 131 in Q1 2020.
- Jennison Associates's portfolio value fell 17% quarter-over-quarter to $82.3B.
Based on Jennison Associates's 13F filing for Q1 2020, filed 6 May 2020.